BBNX
Beta Bionics, Inc.
-1.15 (-5.18%)21.03USD1.5M成交股數946M市值–本益比(近四季)8.0股價營收比+37.8%營收年增(近四季)2026-10-27下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|
| 營收 | 32.0M+81% | 27.6M+35% | 27.3M+63% | 23.2M+54% | 17.6M+36% | 20.4M | 16.7M | 15.0M | 12.9M |
| 營業成本 | 13.1M | 11.2M | 12.1M | 10.7M | 8.7M | 8.8M | 7.8M | 7.0M | 5.7M |
| 毛利 | 18.9M+111% | 16.4M+41% | 15.1M+70% | 12.5M+55% | 9.0M+25% | 11.7M | 8.9M | 8.1M | 7.2M |
| 毛利率 | 59.0% | 59.5% | 55.5% | 53.8% | 50.9% | 57.2% | 53.4% | 53.7% | 55.7% |
| 研發費用 | 10.2M | 10.4M | 8.2M | 8.9M | 7.6M | 9.2M | 5.1M | 6.4M | 5.5M |
| 銷售管理費用 | 9.6M | 9.6M | 7.9M | 7.9M | 6.6M | 4.7M | 5.1M | 4.5M | 3.5M |
| 營業利益 | −25.6M+37% | −24.3M+86% | −17.0M+55% | −19.9M+69% | −18.6M+97% | −13.0M | −11.0M | −11.8M | −9.5M |
| 營業利益率 | -79.9% | -87.9% | -62.5% | -85.5% | -105.7% | -63.8% | -65.7% | -78.3% | -73.1% |
| 稅後淨利 | −23.4M-18% | −21.9M+21% | −14.2M+46% | −16.9M+17% | −28.7M+130% | −18.1M | −9.7M | −14.5M | −12.4M |
| 淨利率 | -73.1% | -79.3% | -52.1% | -72.6% | -162.5% | -88.6% | -58.3% | -96.1% | -96.3% |
| 稀釋 EPS | -0.53-43% | -0.49-82% | -0.33-77% | -0.39-84% | -0.93-55% | -2.70 | -1.46 | -2.37 | -2.07 |
| 稀釋股數 | 44.5M | 44.4M | 43.6M | 43.4M | 30.7M | 6.4M | 6.7M | 6.1M | 6.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 44.3M | 30.2M | 38.5M | 35.1M | 42.5M | 30.4M | 17.5M | 13.0M | 22.1M |
| 應收帳款 | 18.1M | 15.8M | 11.5M | 11.4M | 9.1M | 12.0M | – | – | – |
| 存貨 | 23.9M | 23.7M | 20.4M | 17.3M | 15.7M | 13.3M | – | – | – |
| 總資產 | 292M | 304M | 330M | 330M | 338M | 150M | – | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – |
| 總負債 | 36.0M | 33.2M | 35.3M | 28.3M | 24.3M | 73.6M | – | – | – |
| 股東權益 | 256M | 271M | 295M | 302M | 314M | −245M | −229M | −221M | −214M |
| 負債比 | 12.3% | 10.9% | 10.7% | 8.6% | 7.2% | 49.2% | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −23.8M | – | – | −20.0M+64% | – | – | – | −12.1M |
| 資本支出 | – | 1.4M | – | – | 333K | – | – | – | 406K |
| 自由現金流 | – | −25.2M | – | – | −20.3M+62% | – | – | – | −12.6M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -91.3% | – | – | -115.1% | – | – | – | -97.0% |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 100M | +53.9% | −73.2M | -73.0% | -1.81 | −56.2M |
| FY2024 | 65.1M | +442.9% | −54.8M | -84.1% | -8.60 | −51.7M |
| FY2023 | 12.0M | – | −44.1M | -367.6% | -8.31 | −32.8M |